Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Men and Providers Preventing Suicide (MAPS)
NCT02986113 · View on ClinicalTrials.gov ↗
Study Summary
This study will determine if suicidal middle-aged men who use a personalized computer program addressing suicide risk before a primary care visit are more likely to discuss suicide and accept treatment, reducing their suicide preparatory behaviors and thoughts.This is important because half of all men who die by suicide visit primary care within a month of death, yet few broach the topic, missing chances for prevention.
Conditions Studied
Interventions
- BEHAVIORAL MAPS tailored multimedia patient activation program
- BEHAVIORAL Sleep hygiene video
- BEHAVIORAL Telephone evidence-based follow-up care
- BEHAVIORAL Commitment to Living for Primary Care
Study Locations (2)
California
- Palo Alto Medical Foundation Research Institute — Palo Alto
- University of California Davis Health System — Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2016-12 |
| Est. Completion | 2019-09 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02986113
The ClinicalTrials.gov registry entry for NCT02986113 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 653 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 3 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 4 interventions — of which MAPS tailored multimedia patient activation program is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT02986113 reports 2 study locations spanning 1 distinct geographic area — top geographies include California. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT02986113 about?
NCT02986113 is a clinical study titled "Men and Providers Preventing Suicide (MAPS)". This study will determine if suicidal middle-aged men who use a personalized computer program addressing suicide risk before a primary care visit are more likely to discuss suicide and accept treatment, reducing their suicide preparatory behaviors and thoughts.This is important because half of all m...
What is the current status of trial NCT02986113?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2016-12. Estimated completion is 2019-09.
What conditions does trial NCT02986113 study?
This clinical trial studies the following conditions: Suicidal Ideation, Suicide, Attempted, Suicidal Intention. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT02986113?
The interventions under investigation include: MAPS tailored multimedia patient activation program (BEHAVIORAL), Sleep hygiene video (BEHAVIORAL), Telephone evidence-based follow-up care (BEHAVIORAL), Commitment to Living for Primary Care (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT02986113?
This trial is sponsored by University of California, Davis, which has 653 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT02986113 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.